Be part of the knowledge.™

Oncology and Hematology

838

LikeLikedUnlike

121-135 of 290

Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
CME/CE
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
- Kevin Kalinsky MD, MS
  Peer
- Komal Jhaveri, MD, FACP
  Peer
0.50 credits
HER2 in Bladder Cancer: Breaking Through the Molecular Frontier
CME/CE
HER2 in Bladder Cancer: Breaking Through the Molecular Frontier
- Vadim S. Koshkin, MD
  Peer
0.25 credits
Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer
CME/CE Broadcast Replay
Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer
- Vallerie V. McLaughlin, MD
  Peer
- Marsha Burks, BSN, RN
  Peer
- Rajan Saggar, MD
  Peer
1.00 credits
Integrating IV Iron into Cancer Care: An Expert Overview of Best Practices
CME/CE
Integrating IV Iron into Cancer Care: An Expert Overview of Best Practices
- Brian P. McDonough, MD, FAAFP
  Peer
- George M. Rodgers, MD, PhD
  Peer
- Patricia A. Ford, MD
  Peer
0.50 credits
From Risk to Resilience: Best Practices for Improving Outcomes in Early-Stage ER+/HER2- Breast Cancer
CME/CE
From Risk to Resilience: Best Practices for Improving Outcomes in Early-Stage ER+/HER2- Breast Cancer
- Theresa W. Gillespie, PhD, MA, RN, FAAN
  Peer
- Kristi Orbaugh, MSN, RNP, AOCN
  Peer
- Kimberly Podsada, MSN, NP-C
  Peer
1.50 credits
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CE
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
- Neal Shore, MD, FACS
  Peer
- Sarah Psutka, MD, MS
  Peer
0.25 credits
advertisement
Advancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
CME/CE
Advancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
- Pedro Barata, MD, MSc, FACP
  Peer
- Sumanta K. Pal, MD, FASCO
  Peer
1.00 credits
MinuteCE®
Advances in Hemophilia Treatment: Perspectives From Your Colleagues
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 credits 10 episodes
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
MinuteCE®
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
The Impact of Hemophilia Across Patients’ Lives
MinuteCE®
The Impact of Hemophilia Across Patients’ Lives
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
MinuteCE®
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits
Evaluating Emerging Treatment Options: Rebalancing Therapies
MinuteCE®
Evaluating Emerging Treatment Options: Rebalancing Therapies
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
advertisement
The Promise and Future of Gene Therapy
MinuteCE®
The Promise and Future of Gene Therapy
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
MinuteCE®
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
MinuteCE®
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended